This Article Full Text Full Text (PDF) All Versions of this Article: 34/7/1575    most recent 01.STR.0000077925.16041.6Bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Siritho, S. Articles by Donnan, G. A. Search for Related Content PubMed PubMed Citation Articles by Siritho, S. Articles by Donnan, G. A. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Cerebrovascular disease/stroke Primary and Secondary Stroke Prevention Risk Factors for Stroke Epidemiology

(Stroke. 2003;34:1575.)
© 2003 American Heart Association, Inc.

Original Contributions

Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill

The Melbourne Risk Factor Study (MERFS) Group

Sasitorn Siritho, MD; Amanda G. Thrift, PhD; John J. McNeil, PhD; Roger X. You, PhD; Stephen M. Davis, MD Geoffrey A. Donnan, MD

From the National Stroke Research Institute (S.S., A.G.T., R.X.Y., G.A.D.) and Neurology Department (S.S., G.A.D.), Austin & Repatriation Medical Centre, West Heidelberg; Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Prahran (A.G.T., J.J.M.); Department of Medicine, University of Melbourne, Melbourne (G.A.D.); and Neurology Department, Royal Melbourne Hospital, Parkville (S.M.D.), Australia.

Correspondence to Amanda G. Thrift, National Stroke Research Institute, Austin & Repatriation Medical Centre, Neuroscience Bldg, Banksia St, West Heidelberg, 3081, Australia. E-mail thrift{at}austin.unimelb.edu.au

Background and Purpose— Use of oral contraceptives has increased, and there is uncertainty about the stroke risk associated with their use. Our aim was to investigate this issue.

Methods— Using case-control techniques, we identified consecutive women with ischemic stroke from 4 Melbourne hospitals. All patients were between 15 and 55 years of age and had no prior stroke. Neighborhood-based control subjects were individually age-matched (±5 years) and geographically matched to subject cases. A questionnaire administered to participants elicited information about prior exposure to various potential risk factors, including the oral contraceptive pill (OCP).

Results— We included 234 cases and 234 controls (mean age, 42 years). Compared with noncurrent use, current use of the OCP, in doses of 50 µg estrogen, was not associated with an increased risk of ischemic stroke (odds ratio [OR] 1.76; 95% CI, 0.86 to 3.61; P=0.124). Factors associated with an increased risk of ischemic stroke were a history of hypertension (OR, 2.18; 95% CI, 1.22 to 3.91), transient ischemic attack (OR, 8.17; 95% CI, 1.69 to 39.6), previous myocardial infarction (OR, 5.64; 95% CI, 1.04 to 30.61), and diabetes mellitus (OR, 5.42; 95% CI, 1.42 to 20.75); family history of stroke (OR, 2.22; 95% CI, 1.12 to 4.43); and smoking >20 cigarettes per day (OR, 3.68; 95% CI, 1.22 to 11.09).

Conclusions— There was no evidence for an association between ischemic stroke and use of the OCP in low doses (50 µg estrogen) in young Australian women. Other modifiable risk factors such as hypertension, diabetes mellitus, and smoking are important.

Key Words: Australia • case-control studies • risk factors • stroke, ischemic

This article has been cited by other articles:

				Z. Chakhtoura, M. Canonico, A. Gompel, J.-C. Thalabard, P.-Y. Scarabin, and G. Plu-Bureau Progestogen-Only Contraceptives and the Risk of Stroke: A Meta-Analysis Stroke, April 1, 2009; 40(4): 1059 - 1062. [Abstract] [Full Text] [PDF]

				A Pezzini, M Grassi, L Iacoviello, E Del Zotto, S Archetti, A Giossi, and A Padovani Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 271 - 276. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]

				S. B. Ahmed, P. Hovind, H.-H. Parving, P. Rossing, D. A. Price, L. M. Laffel, M. C. Lansang, R. Stevanovic, N. D.L. Fisher, and N. K. Hollenberg Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy Diabetes Care, August 1, 2005; 28(8): 1988 - 1994. [Abstract] [Full Text] [PDF]

				J.-P. Baillargeon, D. K. McClish, P. A. Essah, and J. E. Nestler Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3863 - 3870. [Abstract] [Full Text] [PDF]

				D J Thomas Migraine and ischaemic stroke BMJ, January 8, 2005; 330(7482): 54 - 55. [Full Text] [PDF]

				K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956. [Abstract] [Full Text] [PDF]

				J. P. Pell, G. C. S. Smith, and D. Walsh Pregnancy Complications and Subsequent Maternal Cerebrovascular Events: A Retrospective Cohort Study of 119,668 Births Am. J. Epidemiol., February 15, 2004; 159(4): 336 - 342. [Abstract] [Full Text] [PDF]

				A. Ciccone, M. Melis, S. Siritho, A. G. Thrift, J. J. McNeil, S. M. Davis, and G. A. Donnan Ischemic Stroke Risk in Oral Contraceptive Users * Response Stroke, December 1, 2003; 34 (12): e231 - e231. [Full Text] [PDF]

				The Pill Is Not Linked to Ischemic Stroke Journal Watch Women's Health, September 4, 2003; 2003(904): 2 - 2. [Full Text]